Literature DB >> 29275978

Refining the use of MRI to predict multiple sclerosis.

Anne H Cross1, Robert T Naismith2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 29275978     DOI： 10.1016/S1474-4422(17)30459-3

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  3 in total

1.  Is It Time for Ocrelizumab Extended Interval Dosing in Relapsing Remitting MS? Evidence from An Italian Multicenter Experience During the COVID-19 Pandemic.

Authors:  Aurora Zanghì; Carlo Avolio; Elisabetta Signoriello; Gianmarco Abbadessa; Maria Cellerino; Diana Ferraro; Christian Messina; Stefania Barone; Graziella Callari; Elena Tsantes; Patrizia Sola; Paola Valentino; Franco Granella; Francesco Patti; Giacomo Lus; Simona Bonavita; Matilde Inglese; Emanuele D'Amico
Journal:  Neurotherapeutics       Date:  2022-08-29       Impact factor: 6.088

2.  Lateralization of the Dichotic Digits Test, Central Auditory Processes, and Evoked Potentials in Multiple Sclerosis.

Authors:  Yolanda Peñaloza; Martha Valdivia; Adrián Poblano
Journal:  J Audiol Otol       Date:  2019-11-04

Review 3.  The Microbiome as a Therapeutic Target for Multiple Sclerosis: Can Genetically Engineered Probiotics Treat the Disease?

Authors:  Hannah M Kohl; Andrea R Castillo; Javier Ochoa-Repáraz
Journal:  Diseases       Date:  2020-08-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.